It is also reported that VPA inhibits the ischemia-induced nuclear translocation of nuclear factor-κB (NFκB) activation and matrix metalloproteinase 9 production in vivo and has protective effects against various types of ischemia and reperfusion injury as well as inflammatory diseases [80–84]. Here, MMP9 is linked to ischemia.